30 daysupply is 60.2ml vials(Xiidra)Indicated forthe treatment ofthe signs &symptoms ofDED(M, V, T, X)When TYRVAYAhas not beenused for morethan 5 days, re-prime with 1spray into the air.1%cyclosporine(Vevye)The first andonly prescriptiondrop that directlytargets tearevaporationPatients stayon treatmentlonger thenRestasis andXiidra(Cequa)MoneyBackGuarantee(Vevye)Improvementin visualacuity as earlyas day 56(Cequa)Increase inSchirmer scoreof 10mm overvehicle in 6 mo(Restasis)1-3% of pts.reportedblurred visionand eyeredness(Miebo)82% ofpatientsreportedsneezing(Tyrvaya)100%perfluorohexy-loctane(Miebo)one monthsupply is 60.25ml vials(Cequa)Reduces thesigns of dry eyeby week 12 insome patients(Xiidra)Throatirritation13% ofpatients(Tyrvaya)Fre99.8% ofpatientsreported no ormildstinging/burning(Vevye)e!.09%Cyclosporine(Cequa).03mg ofvarenicline(Tyrvaya)Calcineurininhibitorimmuno-suppressantopthalmicsolution (Cequa)Improvementin cornealstaining afterjust 14 days(Cequa)Ocularburning17%(Restasis)Wait 30minutes toinstill contactlenses(Miebo).05%Cyclosporine(Restasis)Installationsitereactions 8%(Vevye)Availablefor $79(Vevye)2ml in a5ml bottle(Vevye)SymptomaticRelief in 2weeks in 2 outof 4 studies(Xiidra)SymptomImprovementin the first 30days(Vevye)Blurred Visionwas the mostcommon ocularadversereaction(Miebo)Lifitegrast5%(Xiidra)65% of centralcorneas werecompletelyclear at 3months(Cequa)QID(Miebo)Relief frominflammationin the first 15days(Vevye)95% of patientsexperienced noor mildinstallation sitepain (Cequa)Improvementin SchirmerScore at day28(Tyrvaya)30-daysupply is two4.2ml bottles(Tyrvaya)30 daysupply is 60.2ml vials(Xiidra)Indicated forthe treatment ofthe signs &symptoms ofDED(M, V, T, X)When TYRVAYAhas not beenused for morethan 5 days, re-prime with 1spray into the air.1%cyclosporine(Vevye)The first andonly prescriptiondrop that directlytargets tearevaporationPatients stayon treatmentlonger thenRestasis andXiidra(Cequa)MoneyBackGuarantee(Vevye)Improvementin visualacuity as earlyas day 56(Cequa)Increase inSchirmer scoreof 10mm overvehicle in 6 mo(Restasis)1-3% of pts.reportedblurred visionand eyeredness(Miebo)82% ofpatientsreportedsneezing(Tyrvaya)100%perfluorohexy-loctane(Miebo)one monthsupply is 60.25ml vials(Cequa)Reduces thesigns of dry eyeby week 12 insome patients(Xiidra)Throatirritation13% ofpatients(Tyrvaya)Fre99.8% ofpatientsreported no ormildstinging/burning(Vevye)e!.09%Cyclosporine(Cequa).03mg ofvarenicline(Tyrvaya)Calcineurininhibitorimmuno-suppressantopthalmicsolution (Cequa)Improvementin cornealstaining afterjust 14 days(Cequa)Ocularburning17%(Restasis)Wait 30minutes toinstill contactlenses(Miebo).05%Cyclosporine(Restasis)Installationsitereactions 8%(Vevye)Availablefor $79(Vevye)2ml in a5ml bottle(Vevye)SymptomaticRelief in 2weeks in 2 outof 4 studies(Xiidra)SymptomImprovementin the first 30days(Vevye)Blurred Visionwas the mostcommon ocularadversereaction(Miebo)Lifitegrast5%(Xiidra)65% of centralcorneas werecompletelyclear at 3months(Cequa)QID(Miebo)Relief frominflammationin the first 15days(Vevye)95% of patientsexperienced noor mildinstallation sitepain (Cequa)Improvementin SchirmerScore at day28(Tyrvaya)30-daysupply is two4.2ml bottles(Tyrvaya)

Competitive Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. 30 day supply is 60 .2ml vials (Xiidra)
  2. Indicated for the treatment of the signs & symptoms of DED (M, V, T, X)
  3. When TYRVAYA has not been used for more than 5 days, re-prime with 1 spray into the air
  4. .1% cyclosporine (Vevye)
  5. The first and only prescription drop that directly targets tear evaporation
  6. Patients stay on treatment longer then Restasis and Xiidra (Cequa)
  7. Money Back Guarantee (Vevye)
  8. Improvement in visual acuity as early as day 56 (Cequa)
  9. Increase in Schirmer score of 10mm over vehicle in 6 mo (Restasis)
  10. 1-3% of pts. reported blurred vision and eye redness (Miebo)
  11. 82% of patients reported sneezing (Tyrvaya)
  12. 100% perfluorohexy-loctane (Miebo)
  13. one month supply is 60 .25ml vials (Cequa)
  14. Reduces the signs of dry eye by week 12 in some patients (Xiidra)
  15. Throat irritation 13% of patients (Tyrvaya)
  16. Fre99.8% of patients reported no or mild stinging/burning (Vevye)e!
  17. .09% Cyclosporine (Cequa)
  18. .03mg of varenicline (Tyrvaya)
  19. Calcineurin inhibitor immuno-suppressant opthalmic solution (Cequa)
  20. Improvement in corneal staining after just 14 days (Cequa)
  21. Ocular burning 17% (Restasis)
  22. Wait 30 minutes to instill contact lenses (Miebo)
  23. .05% Cyclosporine (Restasis)
  24. Installation site reactions 8% (Vevye)
  25. Available for $79 (Vevye)
  26. 2ml in a 5ml bottle (Vevye)
  27. Symptomatic Relief in 2 weeks in 2 out of 4 studies (Xiidra)
  28. Symptom Improvement in the first 30 days (Vevye)
  29. Blurred Vision was the most common ocular adverse reaction (Miebo)
  30. Lifitegrast 5% (Xiidra)
  31. 65% of central corneas were completely clear at 3 months (Cequa)
  32. QID (Miebo)
  33. Relief from inflammation in the first 15 days (Vevye)
  34. 95% of patients experienced no or mild installation site pain (Cequa)
  35. Improvement in Schirmer Score at day 28 (Tyrvaya)
  36. 30-day supply is two 4.2ml bottles (Tyrvaya)